Boehringer Ingelheim International GmbH Sustainability Reports
Operates as a global biopharmaceutical entity that researches, develops, and delivers breakthrough therapies and human and animal health products.
Sector: Wholesale & retail
Country: Germany
Exchange: Unlisted
LEI: 529900UYZPE4QQMRRE87
2 reports from 2022 to 2024
